Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome

Human Pathology

Volumn 31, Issue 8, 2000, Pages 905-913

  Kleinschmidt DeMasters, B K ^a,b   Evans, Lynnette C ^a,b   Bobak, Joanna B ^a,b   Lopez Uribe, Daniel ^a,b   Hopper, Deborah ^a,b   Shroyer, A Laurie ^a,b   Shroyer, Kenneth R ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Cardiac Research ^*  (United States)

Author keywords

Glioblastoma; Prognosis; Radiation therapy; Telomerase; Therapy

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CELL HETEROGENEITY; CLINICAL ARTICLE; DOWN REGULATION; ENZYME ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; TISSUE DISTRIBUTION;

EID: 0033858019     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2000.9086     Document Type: Article

References (39)

1. Role of telomerase in cellular proliferation and cancer
2. Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis
3. Telomerase activity in bladder carcinoma and its implications for noninvasive diagnosis by detection of exfoliated cancer cells in urine
4. Detection of telomerase activity in biopsy samples of colorectal cancer
5. Differential telomerase expression in human primary intracranial tumors
6. Telomerase expression in gliomas including the nonastrocytic tumors
7. The significant role of telomerase activity in human brain tumors
8. Telomerase activity in human brain tumours
9. Telomerase expression in intracranial tumours: Prognostic potential for malignant gliomas and meningiomas
10. Le S, Zhu JJ, Anthony DC, et al: Telomerase activity in human gliomas
11. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling
12. Telomerase activity in microdissected human gliomas
13. Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms
14. Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis
15. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
16. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas
17. Long-term survivors of glioblastoma multiforme Clinical and molecular characteristics
18. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors
19. c-myc oncogene family expression in glioblastoma and survival
20. Clinical importance of c-Met protein expression in high grade astrocytic tumors
21. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas
22. Prognostic significance of p53 immunoreactivity in patients with glioma
23. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes
24. Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome
25. Genetic sub-types of human malignant astrocytoma correlate with survival
26. Long-term survival in patients with supratentorial glioblastoma
27. Biological evaluation of biopsies from adult cerebral astrocytomas: Cell-growth/cell-suicide ratios and their relationship to patient survival
28. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy
29. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas Prognostic significance
30. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin Relationships and prognostic value
31. Telomerase activity in ordinary meningiomas predicts poor outcome
32. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer
33. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas
34. Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas
35. Radiation change versus recurrent astrocytoma Diagnostic utility of the proliferation index?
36. Regulation of telomerase activity in immortal cell lines
37. Telomerase activity as a measure for monitoring radiocurability of tumor cells